A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Clinical trial NCT06929273 · RECRUITING

Trial details

NCT number: NCT06929273
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder Type I With Mania

Start date: 2025-07-18
Primary completion: 2028-06-13
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.